Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Biogen logoBiogen BIIB

Biogen said it appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated him as principal accounting officer, with both actions effective as of January 13, 2025 March 1, 2025.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Biogen said it appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated him as principal accounting officer, with both actions effective as of January 13, 2025 March 1, 2025.

  2. The company said Robin Kramer, its current Chief Accounting Officer, will no longer be designated as principal accounting officer as of the effective date of Godbout's appointment. Michael McDonnell will retire on March 1, 2025, and as previously announced, Kramer will become Chief Financial Officer upon his retirement.

  3. Biogen said Godbout is 50 years old and joined the company in 2007. He has served as Global Corporate Controller since October 2023 and was Corporate Controller from September 2019 to October 2023. Before joining Biogen, he worked at PricewaterhouseCoopers LLP. He is a Certified Public Accountant in Massachusetts.

  4. The company said Godbout's base salary will be $400,000 and his target bonus under the annual bonus plan will be 40% of his annual base salary. Upon termination without cause, he would receive a lump sum of at least 6 months of base salary and target bonus, plus 1 month for each full year of service, up to a maximum of 12 months, with 1 year(s) of service as the reference point for the increment. If he is terminated without cause or involuntarily within 2 years after a corporate transaction or change in control, he would receive a lump sum equal to 1 times his annual base salary plus target bonus.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Sean Godbout Appointed Chief Accounting Officer

Biogen said it appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated him as principal accounting officer, with both actions effective as of January 13, 2025 March 1, 2025.

Source · Based on the filing body and exhibits

Robin Kramer Designation Change and Michael McDonnell Retirement

The company said Robin Kramer, its current Chief Accounting Officer, will no longer be designated as principal accounting officer as of the effective date of Godbout's appointment. Michael McDonnell will retire on March 1, 2025, and as previously announced, Kramer will become Chief Financial Officer upon his retirement.

Source · Based on the filing body and exhibits

Godbout Background

Biogen said Godbout is 50 years old and joined the company in 2007. He has served as Global Corporate Controller since October 2023 and was Corporate Controller from September 2019 to October 2023. Before joining Biogen, he worked at PricewaterhouseCoopers LLP. He is a Certified Public Accountant in Massachusetts.

Source · Based on the filing body and exhibits

Godbout Compensation and Severance Terms

The company said Godbout's base salary will be $400,000 and his target bonus under the annual bonus plan will be 40% of his annual base salary. Upon termination without cause, he would receive a lump sum of at least 6 months of base salary and target bonus, plus 1 month for each full year of service, up to a maximum of 12 months, with 1 year(s) of service as the reference point for the increment. If he is terminated without cause or involuntarily within 2 years after a corporate transaction or change in control, he would receive a lump sum equal to 1 times his annual base salary plus target bonus.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.